Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Personalized medicine in rheumatoid arthritis: hopes and challenges.

Bulletin of the NYU hospital for joint diseases - 1 Jan 2007

Bridges S Louis

Abstract excerpt

Clinicians have an increasing number of therapeutic agents available for the treatment of rheumatoid arthritis (RA). Pharmacogenetics, the study of genetic variation underlying differential response to drugs, seeks to improve treatment of individual patients. Multiple markers of treatment response have been analyzed in RA, but many of the studies are small and retrospective in nature. There are many obstacles to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antirheumatic Agents
Share to Arthritis, Rheumatoid
Share to Drug Resistance

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Markers

Share to Genotype

Share to Methyltransferases

Share to Pharmacogenetics

Share to Tumor Necrosis Factor-alpha

Source

Identifiers

PMID: 17922665

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Personalized medicine in rheumatoid arthritis: hopes and challenges.PMID 17922665Read ↗

Genetic data: The new challenge of personalized medicine, insights for rheumatoid arthritis patients.Semantic proximity Read ↗

Pharmacogenomics of biological treatment in rheumatoid arthritis.Semantic proximity Read ↗

Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and PharmacogeneticsSemantic proximity Read ↗

Pharmacogenetics of therapies in rheumatoid arthritis: An update.Semantic proximity Read ↗

Precision medicine and management of rheumatoid arthritis.Semantic proximity Read ↗

Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine.Semantic proximity Read ↗

Pharmacogenomics in rheumatoid arthritis.Semantic proximity Read ↗

The genetic puzzle of rheumatoid arthritis: Causes, progression, and treatmentSemantic proximity Read ↗

Pharmacogenetics in treatment of rheumatoid arthritis.Semantic proximity Read ↗

The genetics of rheumatoid arthritis.Semantic proximity Read ↗

-Omic Approaches and Treatment Response in Rheumatoid ArthritisSemantic proximity Read ↗

The evolution in our understanding of the genetics of rheumatoid arthritis and the impact on novel drug discovery.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.